The wave [4] triangle in IBB is complete, signaling a major buying opportunity. The following move is an impulsive post-triangle thrust, often very strong. Currently, wave 1 of [5] is underway, ...

Vice-president JD Vance has said there is a ‘good chance’ a deal could be reached soon, but what are the red lines, and will ...

Announce initial clinical data from Cohort 1 in the Phase 1/2 trial of PM359 for p47 phox CGD in 2025. The initial readout ...

CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to ...

Updated clinical data in heavily pre-treated, CAR-T naïve patients with B-NHL shows prolonged duration of response, with ...

As lead candidate mipletamig continues to outperform efficacy and safety benchmarks in AML trials, APVO711 exemplifies emerging innovation from Aptevo's proprietary ADAPTIR® platformIn preclinical stu ...

Here is a breakdown of some of the most common legal jargon used in lawsuits surrounding the Trump administration.

The U.S. claims China engages in unfair trade practices, although Beijing has increasingly shown its commitment to the world ...

Uncertainty around ELEVIDYS sales impact Sarepta Therapeutics, Inc. Click here to find out why I downgraded SRPT stock to a ...

How Praxis Packaging delivers flexible, reliable solutions for pharmaceutical contract packaging needs. As pressures on ...

DOUGLAS, ISLE OF MAN / ACCESS Newswire / May 8, 2025 / Agronomics (LSE:ANIC), a leading listed company in the field of clean food, is delighted to announce that its portfolio company, Liberation Labs ...

Investing.com -- Immunocore Holdings plc (NASDAQ: IMCR) shares gained 4.1% after the biotechnology company reported first quarter earnings and revenue that surpassed analyst expectations, driven by ...